On June 27, 2025, Zoetis reported no slowdown in FDA review timelines, Amazon entered pet medication sales, and financial analysts questioned market trends.

The entities involved

• Zoetis →

  American animal health company

  Nothing else this week.

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Amazon →

  American multinational technology company

  • Nvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.Mon 17:31
  • Arianespace, a subsidiary of ArianeGroup, launched satellites for Amazon Leo constellation, supporting ESA's access to space.Mon 17:10

Related events

• FDA is adjusting drug review strategies, showing openness to less data, while China surpasses the U.S. in drug research.Jun 8
• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10
• FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.Thu 15:32
• A 2019 finding indicated that the US regulatory process was slower than European standards.Jul 30
• The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.Sep 22